CA2104096A1 - A method of highlighting intagliations in tablets - Google Patents

A method of highlighting intagliations in tablets

Info

Publication number
CA2104096A1
CA2104096A1 CA002104096A CA2104096A CA2104096A1 CA 2104096 A1 CA2104096 A1 CA 2104096A1 CA 002104096 A CA002104096 A CA 002104096A CA 2104096 A CA2104096 A CA 2104096A CA 2104096 A1 CA2104096 A1 CA 2104096A1
Authority
CA
Canada
Prior art keywords
tablets
solvent
intagliations
highlighting
highlighting intagliations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002104096A
Other languages
French (fr)
Other versions
CA2104096C (en
Inventor
Paul Marie Victor Gilis
Valentin Florent Victor De Conde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Paul Marie Victor Gilis
Valentin Florent Victor De Conde
Janssen Pharmaceutica, Naamloze Vennootschap
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paul Marie Victor Gilis, Valentin Florent Victor De Conde, Janssen Pharmaceutica, Naamloze Vennootschap filed Critical Paul Marie Victor Gilis
Publication of CA2104096A1 publication Critical patent/CA2104096A1/en
Application granted granted Critical
Publication of CA2104096C publication Critical patent/CA2104096C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Abstract

A method of highlighting intagliations in white or colored coated tablets by spraying onto said tablets a suspension com-prising a filling material having a different color, a waxy material and a solvent, and removing the solvent and the excess of fill-ing material and waxy material.
CA002104096A 1991-02-27 1992-02-14 A method of highlighting intagliations in tablets Expired - Lifetime CA2104096C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP91200417 1991-02-27
EP91200417.3 1991-02-27
PCT/EP1992/000358 WO1992015288A1 (en) 1991-02-27 1992-02-14 A method of highlighting intagliations in tablets

Publications (2)

Publication Number Publication Date
CA2104096A1 true CA2104096A1 (en) 1992-08-28
CA2104096C CA2104096C (en) 2003-06-10

Family

ID=8207528

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002104096A Expired - Lifetime CA2104096C (en) 1991-02-27 1992-02-14 A method of highlighting intagliations in tablets

Country Status (16)

Country Link
US (1) US5405642A (en)
EP (2) EP0573462B1 (en)
JP (1) JP3237758B2 (en)
AT (1) ATE143259T1 (en)
AU (1) AU1260392A (en)
CA (1) CA2104096C (en)
DE (1) DE69214130T2 (en)
DK (1) DK0573462T3 (en)
ES (1) ES2094902T3 (en)
GR (1) GR3021929T3 (en)
IE (1) IE75729B1 (en)
MX (1) MX9200831A (en)
NZ (1) NZ241613A (en)
TW (1) TW201697B (en)
WO (1) WO1992015288A1 (en)
ZA (1) ZA921428B (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113945A (en) * 1996-02-26 2000-09-05 L. Perrigo Company Multi-colored medicament
US5827535A (en) * 1996-06-21 1998-10-27 Banner Pharmacaps, Inc. Graphically impressed softgel and method for making same
ES2152065T3 (en) 1997-09-23 2001-01-16 Akzo Nobel Nv DOSED UNITS OF STEROIDS WITH A STAINLESS COATING TO STEROIDS.
US6685961B1 (en) 2000-10-24 2004-02-03 Banner Pharmacaps, Inc. Colored gelatin-based formulations and method
GB0110846D0 (en) * 2001-05-02 2001-06-27 Phoqus Ltd Tablets with coloured patterns
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
JP2005508325A (en) * 2001-09-28 2005-03-31 マクニール−ピーピーシー・インコーポレイテッド Dosage form having an inner core and an outer shell
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US20040048877A1 (en) * 2002-05-22 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions containing flibanserin
CA2489513C (en) * 2002-06-26 2011-05-24 Mars, Incorporated Edible inks for ink-jet printing on edible substrates
US7029112B2 (en) * 2002-08-05 2006-04-18 Mars, Incorporated Ink-jet printing on surface modified edibles and products made
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7906167B2 (en) 2003-03-07 2011-03-15 Mars Incorporated Water based inks for printing on confectionery
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
NZ551340A (en) * 2004-04-22 2010-10-29 Boehringer Ingelheim Int Pharmaceutical composition comprising flibanserin and a melanocortin agonist for the treatment of premenstrual disorder or sexual aversion disorder
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
CA2576812A1 (en) * 2004-09-03 2006-03-09 Boehringer Ingelheim International Gmbh Method for the treatment of attention deficit hyperactivity disorder
US20060088593A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070190133A1 (en) * 2004-10-27 2007-08-16 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088587A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088586A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060087051A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US8383159B2 (en) * 2004-10-27 2013-02-26 Mcneil-Ppc, Inc. Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070281022A1 (en) * 2004-10-27 2007-12-06 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
JP2008538741A (en) * 2005-03-04 2008-11-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Pharmaceutical composition for the treatment and / or prevention of depression
US20060199805A1 (en) * 2005-03-04 2006-09-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
WO2006119884A2 (en) * 2005-05-06 2006-11-16 Boehringer Ingelheim International Gmbh Method for the treatment of drug abuse with flibanserin
CA2608363A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of drug-induced sexual dysfunction
WO2006125041A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of sexual dysfunctions due to medical conditions
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
US7827911B2 (en) * 2005-09-22 2010-11-09 Bpsi Holdings, Inc. Method for printing on tablets
EP1945214A1 (en) * 2005-10-29 2008-07-23 Boehringer Ingelheim International GmbH Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
MY151048A (en) * 2006-05-09 2014-03-31 Boehringer Ingelheim Int Use of flibanserin for the treatment of post-menopausal sexual desire disorders
ATE456369T1 (en) * 2006-06-30 2010-02-15 Boehringer Ingelheim Int FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND ASSOCIATED DISEASES
WO2008006838A1 (en) * 2006-07-14 2008-01-17 Boehringer Ingelheim International Gmbh Use of flibanserin for the treatment of sexual disorders in females
CL2007002214A1 (en) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int PHARMACEUTICAL COMPOSITION IN THE FORM OF COMPRESSED, WHERE AT LEAST THE LENGTH OF THE COMPRESSED IN THE PREVIOUS STATE OF THE APPLICATION IS AT LEAST 7/12 OF THE PILOR DIAMETER OF THE PATIENT AND AFTER INGERING IT IN THE FOOD STATE, THE LENGTH OF THE COMP
EP2054041A2 (en) * 2006-08-14 2009-05-06 Boehringer Ingelheim International GmbH Formulations of flibanserin and method for manufacturing the same
AR062321A1 (en) * 2006-08-25 2008-10-29 Boehringer Ingelheim Int CONTROLLED RELEASE SYSTEM AND METHOD TO MANUFACTURE
UY31335A1 (en) * 2007-09-12 2009-04-30 VASOMOTOR SYMPTOMS TREATMENT

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125490A (en) * 1964-03-17 Tablet with contrasting indicia and method
US3436453A (en) * 1963-06-14 1969-04-01 American Cyanamid Co Surface dyed edible gelatin capsule with pigment marking
FR1426194A (en) * 1964-10-20 1966-01-28 Ile De France New tablet coating technique
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
IE53157B1 (en) * 1981-03-09 1988-08-03 Ici Plc Coated coloured intagliated articles
JPS58152813A (en) * 1982-03-08 1983-09-10 Sumitomo Chem Co Ltd Tablet having clear carved seal and its preparation
JPS58192819A (en) * 1982-05-04 1983-11-10 Sumitomo Chem Co Ltd Production of tablets with clear stamps
KR840000624A (en) * 1982-06-02 1984-02-25 원본미기재 Corrosion inhibitor paint compositions
EP0096982B1 (en) * 1982-06-10 1987-09-16 Imperial Chemical Industries Plc Manufacture of highlighted intagliated articles
US4576646A (en) * 1983-07-06 1986-03-18 Seppic Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
FR2548675B1 (en) * 1983-07-06 1987-01-09 Seppic Sa FILM-FORMING COMPOSITIONS FOR COATING SOLID FORMS OF PHARMACEUTICAL OR FOOD PRODUCTS AND PRODUCTS OBTAINED COATED WITH SUCH COMPOSITIONS
US5006362A (en) * 1988-05-09 1991-04-09 Berwind Pharmaceutical Services, Inc. Branding pharmaceutical dosage forms, food and confectionery products with aqueous ingestible inks
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet

Also Published As

Publication number Publication date
EP0501553A1 (en) 1992-09-02
DE69214130D1 (en) 1996-10-31
MX9200831A (en) 1992-08-01
DK0573462T3 (en) 1996-11-11
JP3237758B2 (en) 2001-12-10
WO1992015288A1 (en) 1992-09-17
TW201697B (en) 1993-03-11
ATE143259T1 (en) 1996-10-15
EP0573462B1 (en) 1996-09-25
AU1260392A (en) 1992-10-06
IE75729B1 (en) 1997-09-24
GR3021929T3 (en) 1997-03-31
US5405642A (en) 1995-04-11
ZA921428B (en) 1993-08-26
EP0573462A1 (en) 1993-12-15
NZ241613A (en) 1993-06-25
DE69214130T2 (en) 1997-02-06
ES2094902T3 (en) 1997-02-01
CA2104096C (en) 2003-06-10
JPH06504935A (en) 1994-06-09
IE920611A1 (en) 1992-09-09

Similar Documents

Publication Publication Date Title
CA2104096A1 (en) A method of highlighting intagliations in tablets
EP0610831A3 (en) Coating composition and a process for preparing coatings with functional groups.
AU6669890A (en) Fluorocarbon-based coating compositions and articles derived therefrom
AU565336B2 (en) Clear top coat for use on color base
AU635630B2 (en) Water resistant composition for coating eyelashes, and preparation method therefor
IL137558A0 (en) A method for the production of sugar-free products containing glucopyranosyl-sorbitol
IL103704A0 (en) Synthetic,monodispersed color pigments and their manufacture
AU7948991A (en) Wax coated paperboard containers
EP0567039A3 (en) Coating composition, coating method and coated articles
AU5236696A (en) Colour dissipatable paint
AU1316292A (en) Coated chewing gum product with emulsifier subcoat
AU6019294A (en) Object-oriented painter maker
AU6899594A (en) Aqueous coating composition and coating process using the same
AU5137890A (en) Coating system exhibiting color travel and opalescent color effects
GB8813557D0 (en) Coating composition & coated paper
AU695060B2 (en) Coloring paint composition
AU7733791A (en) Coating composition and process
AU6768296A (en) Permeation-resistant etfe composition and coatings
AU7267391A (en) Method for coating active principles with zein
KR100199689B1 (en) Preparation process of synthetic paint comprising a yellow dye from cheju island
EP0595341A3 (en) Electrodeposition paint composition.
AU656338B2 (en) Non-mingling multicolor marker and its process
AU2322292A (en) Thermoplastic coating compositions and process using same
AU5006593A (en) Polymer latex composition and coating formulation made therefrom
AU2641992A (en) Coating composition and process

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry